Sign in
4

Changes in Ownership

Oncotelic Therapeutics, Inc. Filed Acc 0001493152-21-017107

CHIEF CLINICAL OFFICER acquired 938,646 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

MAIDA ANTHONY E III · CHIEF CLINICAL OFFICER

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2021-03-31 Conversion : show line 1 in the form +938,646 1,137,314 D

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2021-03-31 Conversion : show line 2 in the form Series A Convertible Preferred Stock −938 0 D
2021-07-08 Grant or award : show line 3 in the form Stock Options +400,000 400,000 D
Loading xslF345X03/ownership.xml…